BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $232,000 | +96.6% | 18,428 | +153.7% | 0.01% | +100.0% |
| Q1 2022 | $118,000 | +321.4% | 7,265 | +266.7% | 0.00% | +300.0% |
| Q3 2021 | $28,000 | -40.4% | 1,981 | -57.1% | 0.00% | -50.0% |
| Q1 2021 | $47,000 | +46.9% | 4,618 | +8.2% | 0.00% | +100.0% |
| Q4 2020 | $32,000 | -5.9% | 4,268 | -40.6% | 0.00% | -75.0% |
| Q2 2020 | $34,000 | +466.7% | 7,184 | +160.5% | 0.00% | +33.3% |
| Q1 2020 | $6,000 | -33.3% | 2,758 | +8.0% | 0.00% | +50.0% |
| Q4 2019 | $9,000 | -55.0% | 2,554 | +1.9% | 0.00% | -75.0% |
| Q1 2019 | $20,000 | +900.0% | 2,507 | +1153.5% | 0.01% | +700.0% |
| Q4 2018 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |